PIK3CA H1047R Mutation Associated With a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated With Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2019.497
Full Text
Open PDFAbstract
Available in full text
Date
February 4, 2020
Authors
Publisher
Korean Cancer Association